{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for benzyl root_notes_note in Note (approximate match)
Status:
Possibly Marketed Outside US
Source:
Devolver Disinfecting Wipes by Devolver Cosmetics Co., Ltd
(2020)
Source URL:
First approved in 2012
Source:
M020
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
21 CFR 333D
(2011)
Source URL:
First approved in 2011
Source:
21 CFR 352
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
NCT00754247: Phase 4 Interventional Completed Keloid
(2006)
Source URL:
First approved in 2004
Source:
Salex by Coria Laboratories
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
21 CFR 352
(2000)
Source URL:
First approved in 2000
Source:
21 CFR 352
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
21 CFR 352
(2010)
Source URL:
First approved in 1989
Source:
NDA050600
Source URL:
Class:
MIXTURE
Status:
Excipient
Source:
9.2mg ORAL TABLET, EXTENDED RELEASE
Source URL:
Class:
POLYMER
Status:
Other
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
M016
(2023)
Source URL:
First approved in 2023
Source:
M016
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
21 CFR 343
(2021)
Source URL:
First approved in 2021
Source:
21 CFR 343
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
NDA212608
(2020)
Source URL:
First approved in 2020
Source:
NDA212608
Source URL:
Class:
POLYMER
